ISRCTN18238599
Completed
N/A
Exploring cerebral structural alterations using MRI and determining their association with clinical parameters in Idiopathic rapid eye movement sleep behavior disorder (iRBD) patients
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Idiopathic rapid eye movement sleep behavior disorder
- Sponsor
- Huashan Hospital, Fudan University
- Enrollment
- 39
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/30688273
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Aged 18–65 years
- •2\. Diagnosed with iRBD according to the clinical and polysomnographic (PSG) characteristics
Exclusion Criteria
- •1\. Signs of parkinsonism
- •2\. Treated with psychotropic medications
- •3\. Evidence of psychiatric disorders or dementia
- •4\. Any cognitive impairment
- •5\. Drug\-induced iRBD
- •6\. Sleep apnea syndrome
- •7\. Electroencephalograph (EEG) abnormalities suggestive of epilepsy, central nervous system comorbidities such as brain tumor, encephalitis, unstable hypertension, and diabetes
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Evaluation of Functional MRI and DTI (Imaging Techniques) in Children With Epilepsy and Focal Brain LesionsEpilepsyNCT00229840Children's Healthcare of Atlanta30
Completed
N/A
Study of Brain Changes Shaped by ExperienceHealthyNeurologic ManifestationsNCT00006424National Institute of Neurological Disorders and Stroke (NINDS)153
Recruiting
N/A
Multimodal Magnetic Resonance Imaging-based Study of Electroconvulsive Efficacy Prediction in Adolescents With Depression: a Multicenter Prospective Cohort StudyMajor Depressive DisorderMagnetic Resonance ImagingElectroconvulsive TherapyNCT05889234First Affiliated Hospital of Chongqing Medical University180
Completed
N/A
Mirror Therapy for Phantom Limb PainAmputationNCT00623818National Institute of Mental Health (NIMH)45
Recruiting
Phase 4
Registry for Migraine - Structural and Functional MRI Before and After Erenumab TreatmentMigraineHeadacheNCT04674020Danish Headache Center250